Replies to post #4641 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Well, that's a hard question, but biotech is back in favor again so the trend is our friend for now. Thus the low to mid teens are in reach by end of summer or early fall IMHO. After that we'll probably need a boost from another deal or, of course, some clearly positive study results. The latter are expected in Q4 so it's not a long wait.
Good luck!
-Fritz